Covid-19 Vaccine Updates: Coronavirus vaccine latest development

Coronavirus is spreading vastly throughout the world and the number of cases is increasing day by day. There is about 31 million Covid-19 cases throughout the world which are increasing at a very faster rate. The only way to stop covid cases is a vaccine, so are you searching for a covid-19 vaccine then you are in the right place.

More than 184 vaccine candidates working throughout the globe. The only hope is from the vaccines which are going through final-stage trials and getting positive results. Some of the vaccines that are performing well in their Phase trials are Oxford University and AstraZeneca’s Vaccine – AZD122, Russia’s vaccine – Sputnik V, United States’s Vaccine – Moderna, China’s vaccine – CoronaVac, and India’s Bharat Biotech’s vaccine – Covaxin. So let’s know all the fact about Covid-19 Vaccine Updates from the world’s top medical universities.

List of Covid-19 Vaccine in Phase Trials –

Oxford University and AstraZeneca’s Vaccine – AZD1222

The Phase 3 trial of Covid-19 Vaccine of Oxford University and AstraZeneca has been stopped for a week due to the illness of one of the volunteers in Britain.

AstraZeneca said that “The standard review process triggered a voluntary pause to vaccination across all global trials to allow the review of safety data by independent committees and international regulators”.

AstraZeneca resumed the Oxford’s Covid-19 vaccine Phase 3 trial in the UK after receiving confirmation from Medicines Health Regulatory Authority (MHRA) for resuming the Oxford University and AstraZeneca AZD1222 Vaccine.

Serum Institute of India also stopped the Phase 3 trials of Oxford University and AstraZeneca AZD1222 Vaccine after they got the news of the illness of study subject in Britain. Serum Institute of India partnered firm Asterzeneca got the clearance of starting the Phase-3 trails again. Serum Institute of India also resumed the Phase 3 trial of the Oxford University’s Covid-19 Vaccine.

 

Russia’s vaccine – Sputnik V

The Coronavirus vaccine of Russia i.e. Sputnik V was the first-ever Covid-19 vaccine registered to Medicines Health Regulatory Authority (MHRA) and got all the regulatory approvals for the public use. More than 10 countries have done the agreement to get Russia’s Covid-19 vaccine Sputnik V. The agreement is done of doing the final Phase-3 trial of the vaccine and to develop and distribute the vaccine.

One of the countries that partnered with Russia’s Covid-19 is India. India’s Dr Reddy’s Laboratories partnered the Russian vaccine developers for the final stage trials i.e. Phase 3 trials and to develop and distribute more than 100 million doses of the Covid-19 vaccine.

 

United States’s Vaccine – Moderna

Moderna vaccine is one the candidate of top three vaccines. It is doing the largest Phase 3 trial in which about 30000 + volunteers enrolled for the participation.

United States Vaccine Candidate Moderna is not developing any Vaccine. For fighting with Covid-19, Moderna is using the genetical approach to generate the antibodies.

 
China’s vaccine – CoronaVac

The Covid-19 vaccine of China named CoronaVac is being developed by Sinovac Biotech Ltd. The CoronoVac has passed Phase 1 and Phase 2 trials successfully with no severe side effects in both the trails.

The Sinovac Biotech Ltd has done CoronaVac Vaccine’s both Phase 1 and Phase 2 trials simultaneously and passed the trials with no severe side effects at the time of the trials. After passing both the trails Sinovac Vaccine entered to its Phase 3 trials.

The Coronavirus vaccine CoronaVac successfully done the trail on people of 60 years and above and got a positive result with no severe side effects. For the phase-3 trial of CoronaVac Covid-19 vaccine about 9000 Brazilians enrolled as a volunteer which is going to be organized at Butantan Institute in Sao Paulo city, Brazil.

Sinovac Biotech Ltd has got the approval for the emergency use of Covid-19 vaccine CoronaVac in China.

 

India’s Bharat Biotech’s vaccine – Covaxin

India’s Coronavirus Vaccine Covaxin developed by Bharat Biotech Ltd has got the approval for the advancement of its Covaxin vaccine.

The Bharat Biotech’s Covaxin is in the second stage of the vaccine trial i.e. in Phase 2. For the Phase 2 trial of Covaxin about 380 participants enrolled.

Bharat Biotech Ltd has a partnership for the development of  Covaxin Covid-19 vaccine with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

Covaxin vaccine is developed in such a way that acts as an inactivated vaccine which is designed to trigger or to generate antibodies against Covid-19 virus.

 

We have finally discussed Covid-19 Vaccine Updates and about the vaccines which are under phase trials by Worlds top Medical Science Institutes like – Oxford University and AstraZeneca’s Vaccine – AZD122, Russia’s vaccine – Sputnik V, United States’s Vaccine – Moderna, China’s vaccine – CoronaVac and India’s Bharat Biotech’s vaccine – Covaxin.